Skip to main content

Welcome to the Raypilot® System Knowledge Centre.

Stay up to date with the latest clinical evidence, news, and events from Micropos Medical. Here you will find publications, product materials, videos, and everything else you need to follow the development of The Raypilot® System.

Publications

Peer-reviewed studies and clinical posters with our editorial summaries: what the study shows, why it matters, and what it means for clinical practice.
View all publications

Radiotherapy and Oncology

2026

Draulans, C. et al.

How to optimise prostate SBRT: ESTRO clinical practice consensus recommendations

A steady rise in the number of patients receiving stereotactic body radiation therapy (SBRT) for primary prostate cancer is expected. Consequently, the current European Society for Radiotherapy and Oncology (ESTRO) ‘how to’ consensus has been developed to offer practical recommendations for the initiation and implementation of prostate SBRT in radiotherapy (RT) departments.

Why it matters: These ‘how to’ clinical practice consensus recommendations, based on the latest available evidence, are developed in cooperation with ESTRO and intended for radiation oncologists, medical physicists and RTTs to jointly implement or optimise prostate SBRT in their radiation oncology department.

Red Journal

2024

Arcangeli, Panizza et al.

ABRUPT: Toxicity and quality of life with dose-escalated SBRT using The Raypilot System

Prospective study of ablative radiotherapy for unfavourable prostate tumours with The Raypilot System, using one single fraction. Reports toxicity rates and quality-of-life outcomes at dose escalation.

Why it matters: Raypilot System-specific clinical data. Measured outcomes from patients treated with this system in routine clinical practice.

The Lancet Oncology

2025

Tree et al.

PACE-C: Moderate hypofractionation vs. SBRT, early toxicity

Head-to-head comparison of moderate hypofractionation and SBRT. Early toxicity results confirm that the increased toxicity seen with SBRT is predominantly urethra-related; the exact issue that The Raypilot System's urethra visualisation addresses. moderate hypofractionation and SBRT

Why it matters: The residual toxicity risk in SBRT is manageable with the right tools. Urethra-sparing technique is the key, and that requires knowing where the urethra is during delivery

Downloads

Brochures, specification sheets, and clinical summaries. All downloadable as PDF.
View all downloads

PDF

The Raypilot® System Folder

An introduction to prostate cancer treatment with The Raypilot® System, including how the system works, the step-by-step treatment process, and patient experience.

Download Raypilot System Folder

PDF

The Raypilot® System Technical Flyer

Technical specifications for The Raypilot® System, including receiver dimensions, catheter specifications, position update performance, and measurement precision data.

Download Raypilot System Technical Flyer

PDF

The Raypilot® System Flyer

An overview of The Raypilot® System for intrafraction motion management, featuring system components, key clinical benefits, and references from treating clinicians.

Download Raypilot System Flyer

Subscribe to Our Newsetter

Follow Us on Social Media

Welcome to follow us for news, insights and updates.